Proxygen GmbH
Back to list
Facts
- Founded
- 2020
- Staff
- 9
- Organization type
- RDM biotech/pharma
- Region
- Vienna
- Focus
- human health
Profile
Proxygen harnesses the cellular protein quality control system to develop therapies against cancer and other life-threatening diseases. We are focused on particular small molecules called “molecular glue degraders” which mediate recruitment of a disease-causing protein to a ubiquitin ligase where it is ubiquitinated and directed to the proteasome for degradation. Hence, instead of merely blocking the function of harmful proteins, molecular glue degraders enable their complete and selective elimi
Similar companies in RDM biotech/pharma
emergentec biodevelopment GmbH
- Organization type
- RDM biotech/pharma
- Region
- Vienna
- Cluster
- LISAvienna
- Focus
- bioinformatics
EBEWE Pharma Ges.m.b.H. Nfg.KG
- Organization type
- RDM biotech/pharma
- Region
- Upper Austria
- Focus
- human health
EUCODIS Bioscience GmbH
- Organization type
- RDM biotech/pharma
- Region
- Vienna
- Cluster
- LISAvienna
- Focus
- industrial processing
Bristol-Myers Squibb GmbH
- Organization type
- RDM biotech/pharma
- Region
- Vienna
- Cluster
- LISAvienna
- Focus
- human health